Decision Aid for Chronic Pain
(PHOENIX Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to create a tool to help patients and doctors discuss stopping long-term opioid treatment. This is important because suddenly stopping opioids can lead to increased pain or the use of unsafe alternatives. The trial will test whether this patient-centered decision aid improves conversations and understanding about stopping opioid use. Participants should have taken opioids for chronic pain for at least six months and be able to read and speak English. As an unphased trial, this study offers a unique opportunity to contribute to developing a tool that could significantly enhance patient-doctor communication.
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop your current medications, but it focuses on people who are currently taking long-term opioid therapy. It seems likely that you will continue your current opioid medication during the study.
What prior data suggests that this decision aid is safe for patients on long-term opioid therapy?
Research has shown that tools like the one tested in this study, which facilitate discussions between patients and doctors about treatment options, are generally well-received. These tools simplify the decision-making process for both parties. Studies have found that they can enhance communication and understanding without causing harm.
No evidence suggests that using these tools leads to negative effects. They provide information and support rather than direct medical treatment, so they don't carry the same risks as medications or surgeries. The tool's main goal is to help people make better choices about their care, especially in challenging situations like changing long-term opioid use. So far, this approach appears safe and helpful for patients.12345Why are researchers excited about this trial?
Researchers are excited about the Decision Aid for chronic pain because it empowers patients to take an active role in their treatment choices. Unlike typical treatments that focus on medication or physical therapy, this approach provides a personalized tool to help patients understand their options and decide what works best for them. This patient-centered strategy aims to improve satisfaction and outcomes by aligning treatment decisions with individual values and preferences.
What evidence suggests that this decision aid is effective for improving patient-provider communication around opioid discontinuation?
Research has shown that decision aids, such as the Patient-centered Decision Aid tested in this trial, help patients better understand their treatment options for chronic pain. While these tools increase knowledge, they might not significantly change other outcomes like pain levels or quality of life. Some studies suggest that using these aids to encourage shared decision-making can lead to better pain management. Specifically, combining patient education with decision aids can improve satisfaction in patient-doctor interactions. Overall, these tools aim to enhance communication and assist patients in making informed choices about stopping opioid use.678910
Who Is on the Research Team?
Clarissa W Hsu, PhD
Principal Investigator
Kaiser Permanente
Are You a Good Fit for This Trial?
This trial is for individuals on long-term opioid therapy (LTOT) who are being encouraged or required to stop taking opioids. Participants should be willing to discuss their experiences and use a decision aid designed to improve communication with providers about discontinuing LTOT.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Interviews and Decision Aid Development
Interviews with patients and doctors about discontinuing LTOT to develop a patient-centered decision aid
Decision Aid Pilot Test
Pilot testing of the decision aid with 30 patients currently on LTOT to assess implementation feasibility, acceptability, and knowledge transfer
Follow-up
Participants are monitored for safety and effectiveness after the pilot test
What Are the Treatments Tested in This Trial?
Interventions
- Patient-centered Decision Aid
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kaiser Permanente
Lead Sponsor
University of Washington
Collaborator
University of Arkansas
Collaborator